A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Estrogen Receptors: How Do They Signal and What Are Their Targets | Physiological Reviews
EREs).
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers | HTML
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
IJMS | Free Full-Text | The Role of ERα36 in Development and Tumor Malignancy | HTML
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α* - Journal of Biological Chemistry
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Dual-mechanism estrogen receptor inhibitors | PNAS
New insights into acquired endocrine resistance of breast cancer
Dual-mechanism estrogen receptor inhibitors | PNAS
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
